News & Updates

Show Multimedia Only

Parkinson’s disease: More hours of good on-time with extended- vs immediate-release carbidopa-levodopa

05 Sep 2023 by

IPX203, a new oral extended-release (ER) carbidopa-levodopa (CD-LD) combination, provides more hours of good on-time per day than immediate-release (IR) CD-LD, according to results of a phase III clinical trial in patients with Parkinson’s disease (PD).

05 Sep 2023

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Women who conceive following infertility treatment appear to have a higher likelihood of stroke-related hospitalization within 12 months of delivery as compared with those who spontaneously conceive, according to a study.

04 Sep 2023

Dancing, moving may reduce BMD loss in patients admitted in psychiatric hospitals

02 Sep 2023

Dance/movement therapy (DMT) rehabilitation appears to be beneficial to patients with schizophrenia who are admitted in psychiatric hospitals, yielding improvements in bone mineral density (BMD) and balance, as shown in a study.

02 Sep 2023

Meta-analysis: TTFields added to SoC improves OS in newly diagnosed GBM in real-world setting

01 Sep 2023 by

Results of a systematic review and meta-analysis suggest that adding tumour-treating fields (TTFields) to standard chemoradiotherapy (CRT) significantly prolongs overall survival (OS) for patients with newly diagnosed glioblastoma multiforme (GBM) treated in the real-world setting.

01 Sep 2023

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

01 Sep 2023

Product Highlight - Fosphenytoin sodium (Aurantin)

31 Aug 2023

Fosphenytoin sodium (Aurantin) - Soln for inj (vial) 75 mg/mL

31 Aug 2023

Infrequent bowel movement tied to cognitive decline

28 Aug 2023 by

A study presented at AAIC 2023 has shown a link between less frequent bowel movement (ie, one every 3+ days) and cognitive function in adults.

28 Aug 2023

Ginkgo diterpene lactone meglumine improves acute ischaemic stroke outcomes

25 Aug 2023

Treatment with ginkgo diterpene lactone meglumine (GDLM) leads to favourable functional outcomes in individuals who sustained acute ischaemic stroke (AIS), as shown in a study.

25 Aug 2023

Coffee ups risk of intracranial aneurysm

24 Aug 2023

Drinking coffee appears to increase the risk of intracranial aneurysm (IA) and associated haemorrhage, reveals a study. Thus, coffee intake must be reduced for people at risk of IA.

24 Aug 2023

High social engagement in midlife tied to lower dementia risk

23 Aug 2023 by

Higher levels of social engagement during midlife are associated with a reduced risk of dementia later in life, according to a study presented at AAIC 2023.

23 Aug 2023

News & Updates

Showing Neurology articles

Showing

Specialty:

Parkinson’s disease: More hours of good on-time with extended- vs immediate-release carbidopa-levodopa

Infertility treatment carries increased risk of stroke hospitalization

Dancing, moving may reduce BMD loss in patients admitted in psychiatric hospitals

Meta-analysis: TTFields added to SoC improves OS in newly diagnosed GBM in real-world setting

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Product Highlight - Fosphenytoin sodium (Aurantin)

Infrequent bowel movement tied to cognitive decline

Ginkgo diterpene lactone meglumine improves acute ischaemic stroke outcomes

Coffee ups risk of intracranial aneurysm

High social engagement in midlife tied to lower dementia risk